| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 09/17/1997 | EP0795326A1 Ocular tension depressant |
| 09/17/1997 | EP0794944A1 Perhydroisoindole derivatives as antagonists of substance p |
| 09/17/1997 | EP0794772A1 A method for enhancing outflow of aqueous humor in treatment of glaucoma |
| 09/17/1997 | CN1159804A Dihydrobenzofuranes |
| 09/17/1997 | CN1159323A Medicinal compositionf or preventing and curing xerophthalmia and disease led themby, method and apparatus |
| 09/16/1997 | US5668156 Di (aromatic) compounds and their use in human and veterinary medicine and in cosmetics |
| 09/15/1997 | CA2200032A1 Axial length control agent and agent for prophylaxis and treatment of myopia or hyperopia |
| 09/12/1997 | WO1997032865A1 Novel aryl glycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds |
| 09/12/1997 | WO1997032598A2 Vaccines |
| 09/11/1997 | DE19608665A1 Neue Arylglycinamidderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen New Arylglycinamidderivate, processes for their preparation containing these compounds and pharmaceutical compositions |
| 09/10/1997 | EP0793665A1 Heterocyclic compounds and their preparation and use |
| 09/10/1997 | EP0793658A1 Oxazole derivatives as antagonists of alpha-1c adrenergic receptors |
| 09/10/1997 | EP0793643A1 Matrix metalloprotease inhibitors |
| 09/10/1997 | EP0793641A1 Metalloproteinase inhibitors |
| 09/09/1997 | US5665773 Cloprostenol and fluprostenol analogues and their use to treat glaucoma and ocular hypertension |
| 09/09/1997 | US5665749 For treating inflammation, allergies or cardiovascular diseases in mammals |
| 09/09/1997 | US5665745 1,2,5-thiadiazole derivatives for treating diseases of central nervous system |
| 09/09/1997 | US5665733 3-phenylisoquinol-1(2H)-one derivatives their preparation and their therapeutic application |
| 09/09/1997 | CA2133966C Ocular androgen therapy in sjogren's syndrome |
| 09/04/1997 | WO1997031895A2 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| 09/04/1997 | WO1997031636A1 Novel indole and benzothiazole derivatives |
| 09/04/1997 | CA2247208A1 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| 09/04/1997 | CA2246813A1 Novel indole and benzothiazole derivatives |
| 09/03/1997 | EP0792644A1 Aqueous eye drops containing apafant as principal agent |
| 09/03/1997 | EP0792643A1 Use of an aldose reductase inhibitor for reducing non-cardiac tissue damage |
| 09/03/1997 | CN1035764C Process for preparing 13,14-dihydro-15(R)-17-phenyl-18'19'20-trinor-PGF 2 alpha esters |
| 09/02/1997 | US5663412 Antihistamines |
| 09/02/1997 | US5663380 Cysteine protease inhibitors containing heterocyclic leaving groups |
| 09/02/1997 | US5663347 Regulators of cell proliferation and differentiation; treatment of skin disorders; anticarcinognic agents |
| 09/02/1997 | US5663205 Pharmaceutical composition for use in glaucoma treatment |
| 09/02/1997 | US5663170 Diabetes |
| 08/28/1997 | WO1997030990A1 Novel substituted n-methyl-n-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases |
| 08/28/1997 | WO1997030989A1 Novel substituted n-methyl-n-(4-(4-(1h-benzimidazol-2-yl-amino)piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases |
| 08/28/1997 | WO1997030724A1 Recombinant tissue plasminogen activator (rtpa) for preventing secondary cataracts following cataract operations |
| 08/28/1997 | WO1997030722A1 Use of glial neurotrophic factor (gdnf) for treatment of hearing disorders |
| 08/28/1997 | WO1997030704A2 Use of carbonic anhydrase inhibitors for treating macular edema |
| 08/28/1997 | DE19606551A1 rt-PA zur Prävention des Nachstars nach Kataraktoperation rt-PA for the prevention of cataract after cataract surgery |
| 08/28/1997 | CA2247460A1 Recombinant tissue plasminogen activator (rtpa) for preventing secondary cataracts following cataract operations |
| 08/27/1997 | EP0791355A1 Method of reducing tissue damage associated with ischemia |
| 08/27/1997 | EP0790825A1 Nk-1 receptor antagonists for the treatment of eye disorders |
| 08/27/1997 | EP0575454B1 Use of cucurbitine for the preparation of a cosmetic or pharmaceutical, particularly dermatological, antiallergic composition and method involving application thereof |
| 08/27/1997 | EP0520005B1 Nitroxides for weight reduction |
| 08/27/1997 | CN1158121A Indolizine SPLA2 inhibitors |
| 08/26/1997 | US5661178 Method for effecting vasodilation with (1,5-inter)aryl prostaglandin derivatives |
| 08/26/1997 | US5661162 4-aminomethyl/thiomethyl/sulfonylmethyl-4-phenylpiperdines as tachykinin receptor antagonists |
| 08/21/1997 | WO1997030178A2 Diagnosing trinucleotide repeat diseases and genes involved therein |
| 08/21/1997 | WO1997029756A1 Method of treating otitis media with uridine triphosphates and related compounds |
| 08/21/1997 | WO1997029752A1 Storage-stable prostaglandin compositions |
| 08/21/1997 | WO1997029741A1 Polymeric quaternary ammonium compounds and their use as ophthalmic antimicrobials |
| 08/21/1997 | WO1997023507A3 New form of amphiregulin, methods for producing and using the same and compositions comprising the same |
| 08/21/1997 | CA2246581A1 Method of treating otitis media with uridine triphosphates and related compounds |
| 08/21/1997 | CA2246362A1 Diagnosing trinucleotide repeat diseases and genes involved therein |
| 08/20/1997 | EP0789762A1 Methods for the diagnosis of glaucoma |
| 08/20/1997 | EP0789687A1 Ep 2?-receptor agonists as agents for lowering intraocular pressure |
| 08/20/1997 | EP0789592A1 Ocular gene therapy |
| 08/20/1997 | EP0579833B1 Ethanolamine derivatives with anti-pollakiuria activity |
| 08/20/1997 | CN1157136A Pharmaceutical agents for treatment of acute and chronic inflammatory diseases |
| 08/19/1997 | US5658950 Therapeutic agent for glaucoma and ocular hypotensive agent |
| 08/19/1997 | US5658932 Azacyclic compounds; cognitive function stimulants; alzheimer's disease |
| 08/19/1997 | US5658918 Purine-2,8-diones and pharmaceutically acceptable salts thereof |
| 08/19/1997 | US5658897 Cyclopentane(ene) heptanoic or cyclopentane(ene) heptenoic acid, 2-hydrocarbyl phosphinyloxyalkyl or phosphonamidoalkyl as therapeutic agents |
| 08/14/1997 | WO1997029131A1 HUMAN ANTIBODIES THAT BIND HUMAN TNF$g(a) |
| 08/14/1997 | WO1997029100A1 Heterocyclic diaryl compounds, pharmaceutical and cosmetic compositions containing same, and uses thereof |
| 08/13/1997 | EP0788792A1 Matrix type patch preparation |
| 08/13/1997 | EP0788514A1 Binding agents for treatment of inflammatory, autoimmune or allergic diseases |
| 08/13/1997 | EP0788513A1 Binding agents to cd23 |
| 08/13/1997 | EP0788509A1 Therapeutic peptide derivatives |
| 08/13/1997 | EP0788490A1 Bisarylcarbinol cinnamic acids as inhibitors of leukotriene biosynthesis |
| 08/13/1997 | EP0788383A2 Modulation of cell proliferation and wound healing |
| 08/13/1997 | EP0788368A1 Therapeutic composition for replacing and/or supplementing body fluids |
| 08/13/1997 | EP0788359A1 Compositions useful for the preparation of medicines for treating a variety of intractable disorders |
| 08/12/1997 | US5656726 Antiinflammatory agents, antiarthritic agents |
| 08/12/1997 | US5656660 Amine or guanidine group-containing tryptase inhibitor |
| 08/07/1997 | WO1997028153A1 Chinoline and benzimidazole derivatives as bradykinin agonists |
| 08/07/1997 | WO1997017085A3 A method for inhibiting attachment of h. influenzae to human cells using phosphorylated recombinant human beta-casein |
| 08/06/1997 | EP0787492A1 Use of nitroxides and oxazolidines for protection against ionising radiation and oxidative stress |
| 08/06/1997 | EP0787131A1 Benzenesulphonamide derivatives as bradykinine antagonists |
| 08/06/1997 | EP0787016A1 Secretory leukocyte protease inhibitor as an inhibitor of tryptase |
| 08/06/1997 | EP0786997A1 Muscarine antagonists |
| 08/06/1997 | EP0786995A1 Use of receptor potentiators |
| 08/06/1997 | EP0786994A2 Use of chloride channel blockers for reducing intraocular pressure |
| 08/06/1997 | CN1156451A Quinoline derivatives as tachykinin NK3 receptor antagonists |
| 08/05/1997 | US5654445 Intermediates for renin inhibitors, hypotensive agents |
| 08/05/1997 | US5654331 Diaromatic compounds derived from a salicylic unit and their use in human and veterinary medicine and in cosmetics |
| 08/05/1997 | US5654329 1,3-benzodioxole and 1,2-dialkoxybenzene derivatives as ocular hypotensive agents |
| 08/05/1997 | US5654326 1H-indole-3-glyoxylamide SPLA2 inhibitors |
| 08/05/1997 | US5654279 Tissue destruction in cryosurgery by use of thermal hysteresis |
| 07/31/1997 | WO1997026872A1 Remedy for keratoconjunctival diseases |
| 07/30/1997 | EP0785948A1 Analogs of keratinocyte growth factor |
| 07/30/1997 | EP0785781A2 Use of indole derivatives for the treatment of dermatological disorders peripheral neuropathied, arthritis, headache, orofacial pain, allergic or chronic obstructive airways disease, glaucoma and ocular inflammation |
| 07/30/1997 | EP0785715A1 Method for delipidation of skin and cerumen removal |
| 07/30/1997 | CN1155838A Indolinone compounds for the treatment of disease |
| 07/29/1997 | US5652227 Inhibition of the degradation of connective tissue matrix protein components in mammals |
| 07/24/1997 | WO1997026356A1 PHENYLALANYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026355A1 NOVEL VALYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026354A1 HISTIDYL-tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026351A1 STAPHYLOCOCCUS AUREUS TYROSYL-tRNA SYNTHETASE |
| 07/24/1997 | WO1997026349A1 LEUCYL tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026347A1 ARGINYL tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026346A1 NOVEL TRYPTOPHANYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS |